Nanobody Therapeutics Market Size, Share & Industry Analysis, By Molecule (Caplacizumab (Cablivi), Ozoralizumab (Nanozora), Envafolimab, and Others), By Nanobody Type (Bivalent, Trivalent, Fc-fused / Half-life Extended, and Others), By Disease Indication (Hematological / Blood Disorders, Rheumatoid Arthritis, Oncology, and Others) By Route of Administration (Intravenous, Subcutaneous, and Others), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, and Others), and Regional Forecast, 2026-2034